Synthesis, characterization, antimicrobial activity and LPS-interaction properties of SB041, a novel dendrimeric peptide with antimicrobial properties

Peptides

Volumn 31, Issue 8, 2010, Pages 1459-1467

  Bruschi, Michela ^a,c   Pirri, Giovanna ^a   Giuliani, Andrea ^a   Nicoletto, Silvia Fabiole ^a   Baster, Izabela ^b   Scorciapino, Mariano Andrea ^c,d   Casu, Mariano ^c   Rinaldi, Andrea C ^c  

^a Research and Development Unit   (Italy)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c UNIVERSITY OF CAGLIARI   (Italy)

^d CNR   (Italy)

Author keywords

Binding; LPS Endotoxin; Neutralization; NMR; Peptidomimetics; Sepsis; Synthetic peptides

Indexed keywords

COLISTIN; ENDOTOXIN; LIPOPOLYSACCHARIDE; PEPTIDE SB041; POLYMYXIN B; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIMICROBIAL ACTIVITY; ARTICLE; CELL ASSAY; CELL LINE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ESCHERICHIA COLI; NEGIBACTERIA; POSIBACTERIA; PSEUDOMONAS AERUGINOSA;

EID: 78249271990     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.04.022     Document Type: Article

References (34)

1. Beutler B, Rietschel ETh. Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 2003;3:169-176
2. Biomolecules Magnetic Resonance Data Bank. http://www.bmrb.wisc.edu/2009.
3. Bracci L, Falciani C, Lelli B, Lozzi L, Runci Y, Pini A, et al. Synthetic peptides in the form of dendrimers become resistant to protease activity. J Biol Chem 2003;278:46590-46595
4. Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 2005;3:238-250
5. Cavanagh J, Fairbrother WJ, Palmer III AG, Rance M, Skelton NJ. Protein NMR spectroscopy. Principles and practice. 2nd ed. Oxford: Elsevier Academic Press; 2007.
6. Committee for Clinical Laboratory Standards. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes. Approved Standard. NCCLS document M24-A. Wayne: NCCLS; 2006.
7. Conlon JM, Al-Ghaferi N, Abraham B, Leprince J. Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents. Methods 2007;42:349-357
8. Easton DM, Nijnik A, Mayer ML, Hancock RE. Potential of immunomodulatory host defense peptides as novel anti-infectives. Trends Biotechnol 2009;27:582-590
9. Falciani C, Lozzi L, Pini A, Corti F, Fabbrini M, Bernini A, et al. Molecular basis of branched peptides resistance to enzyme proteolysis. Chem Biol Drug Des 2007;69:216-221
10. Freudenberg MA, Tchaptchet S, Keck S, Fejer G, Huber M, Schültze N, et al. Lipopolysaccharide sensing an important factor in the innate immune response to Gram-negative bacterial infections: benefits and hazards of LPS hypersensitivity. Immunobiology 2008;213:193-203.
11. Giacometti A, Cirioni O, Ghiselli R, Mocchegiani F, Orlando F, Silvestri C, et al. Interaction of temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. Antimicrob Agents Chemother 2006;50:2478-2486
12. Giuliani A, Pirri G, Bozzi A, Di Giulio A, Aschi M, Rinaldi AC. Antimicrobial peptides: natural templates for synthetic membrane-active compounds. Cell Mol Life Sci 2008;65:2450-2460
13. Giuliani A, Pirri G, Nicoletto SF. Antimicrobial peptides: an overview of a promising class of therapeutics. Centr Eur J Biol 2007;2:1-33.
14. Giuliani A, Pirri G, Rinaldi AC. Antimicrobial peptides: the LPS connection. Methods Mol Biol 2010;618:137-154
15. Giuliani A, Rinaldi AC. Antimicrobial peptides. Methods and protocols. Methods in molecular biology, vol.618. New York: Humana Press; 2010.
16. Hancock REW, Sahl H-G. Antimicrobial and host-defense peptides as new antiinfective therapeutic strategies. Nat Biotechnol 2006;24:1551-1557
17. Keeler J. Understanding NMR spectroscopy. Chichester: Wiley & Sons; 2005.
18. Lancelin JM, Gans P, Bouchayer E, Bally I, Arlaud GJ, Jacquot JP.NMRstructures of amitochondrial transit peptide from the green alga Chlamydomonas reinhardtii. FEBS Lett 1996;391:203-208
19. Li J, Nation RL, Milne RW, Turnidge JD, Coulthard K. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Int J Antimicrob Agents 2005;25:11-25.
20. Melo MN, Ferre R, Castanho MA. Antimicrobial peptides: linking partition, activity and high membrane-bound concentration. Nat Rev Microbiol 2009;7:245-250
21. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Approved standard. 16th Informational Supplement. NCCLS document M100-S16. Wayne: NCCLS; 2006.
22. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. 7th ed. NCCLS document M7-A7. Wayne: NCCLS; 2006.
23. National Committee for Clinical Laboratory Standards. Reference methods for broth dilution antifungal susceptibility testing of yeasts. Approved standard. 2nd ed. NCCLS document M27-A2. Wayne: NCCLS; 2006.
24. Pini A, Giuliani A, Falciani C, Runci Y, Ricci C, Lelli B, et al. Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. Antimicrob Agents Chemother 2005;49:2665-2672
25. Pirri G, Giuliani A, Nicoletto SF, Pizzuto L, Rinaldi AC. Lipopeptides as antiinfectives: a practical perspective. Centr Eur J Biol 2009;4:258-273
26. Radek K, Gallo G. Antimicrobial peptides: natural effectors of the innate immune system. Semin Immunopathol 2007;29:27-43.
27. Rosenfeld Y, Papo N, Shai Y. Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides: peptide properties and plausible modes of action. J Biol Chem 2006;281:1636-1643
28. Rosenfeld Y, Shai Y. Lipopolysaccharide (endotoxin)-host defense antibacterial peptides interactions: role in bacterial resistance and prevention of sepsis. Biochim Biophys Acta 2006;1758:1513-1522
29. Scott RW, DeGrado WF, Tew GN. De novo designed synthetic mimics of antimicrobial peptides. Curr Opin Biotechnol 2008;19:620-627
30. Sonnichsen FD, Van Eyk JE, Hodges RS, Sykes BD. Effect of trifluoroethanol on protein secondary structure: an NMR and CD study using a synthetic actin peptide. Biochemistry 1992;31:8790-8798
31. Tam JP, Lu YA, Yang JL. Antimicrobial dendrimeric peptides. Eur J Biochem 2002;269:923-932
32. Wood SJ, Miller KA, David SA. Anti-endotoxin agents. 1. Development of a fluorescent probe displacement method optimized for the rapid identification of lipopolysaccharide-binding agents. Combin Chem High Throughput Screen 2004;7:239-249
33. Wüthrich K. NMR of proteins and nucleic acids. Chichester: Wiley & Sons; 1986.
34. Zhang L, Falla TJ. Host defense peptides for use as potential therapeutics. Curr Opin Investig Drugs 2009;10:164-171